Skip to main content
. 2022 Sep 9;10(9):1505. doi: 10.3390/vaccines10091505

Table 1.

Sociodemographic characteristics of 217 women enrolled in the evaluation group and the study groups A and B.

Evaluation Group
(n = 69)
Study Group A
(n = 68)
Study Group B
(n = 80)
Standardized Difference 1
Evaluation Group vs. A Evaluation Group vs. B A vs. B
Age, years (IQR) 31.5 (28.1–36.4) 32.6 (28.9–36.0) 32.5 (28.8–35.7) −0.03 −0.02 −0.01
Migration background, n (%) 37 (53.6%) 40 (58.8%) 49 (61.3%) 0.11 0.15 −0.05
Primipara, n (%) 44 (63.8%) 30 (44.1%) 30 (37.5%) −0.39 −0.49 0.11
Mode of delivery 0.03 0.03 −0.00
Vaginal delivery, n (%) 36 (52.2%) 34 (50.7%) 41 (51.2%)
Cesarean section, n (%) 31 (44.9%) 31 (46.3%) 36 (45.0%)
Instrumental delivery, n (%) 2 (2.9%) 2 (3.0%) 3 (3.8%)
Preterm delivery, n (%) 18 (26.1%) 9 (13.2%) 15 (18.8%) −0.32 −0,19 −0.14

1 Imbalance defined as absolute value greater than 0.20 (small-effect size).